1.8460
+0.0120
+(0.65%)
At close: April 17 at 9:55:01 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 6 |
| Avg. Estimate | 10.38M | 14.22M | 65.53M | 80.01M |
| Low Estimate | 9.07M | 12.1M | 64M | 72.02M |
| High Estimate | 13M | 15.9M | 67.7M | 93.94M |
| Year Ago Sales | 17.07M | 7.98M | 59.34M | 65.53M |
| Sales Growth (year/est) | -39.22% | 78.22% | 10.41% | 22.10% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4QK.F | -- | -- | -- | -- |
| S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 11/22/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 11/15/2024 |
| Reiterates | Benchmark: Hold | 11/4/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/20/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/29/2024 |
| Downgrade | Benchmark: Buy to Hold | 8/19/2024 |
Related Tickers
4AJ0.BE Alk-Abello A/S
19.68
+2.23%
8C5.F Coherus BioSciences, Inc.
0.8802
-4.37%
CXF.F Chimerix, Inc.
7.48
+0.27%
ITH.F Nektar Therapeutics
0.5740
+5.03%
I5X.F Precigen, Inc.
1.1700
-2.42%
LEXXW Lexaria Bioscience Corp.
0.3400
-8.11%
IPIX Innovation Pharmaceuticals Inc.
0.0002
0.00%
NEUP Neuphoria Therapeutics Inc.
5.14
+0.38%
TSVT 2seventy bio, Inc.
4.9800
+0.20%
AEON AEON Biopharma, Inc.
0.4050
+1.28%